Sales of generic oncology drugs industry size are anticipated to reach US$ 24.5 billion in 2022 and US$ 34.8 billion by the end of 2028, rising at a 6% CAGR. The main factor causing cancer in people is the rise in tobacco use and smoking. The human body is vulnerable to cancer due to secondary …